Contractor
ELUSYS THERAPEUTICS INC
PARSIPPANY, NJ
- UEI
- ELP1DCK8L191
- Parent UEI
- HQUBBMC377D4
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$124,523,1231
Awards
2
Agencies served
1
Active from Apr 7, 2026 to Jul 7, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75A50324C00006 ADMINISTRATIVE OBJECT CLASS CODE DEOBLIGATION-ANTHIM (OBILTOXAXIMAB) | Department of Health and Human Services | NJ | Jun 1, 2026 | $124,523,123 |
| HHSO100201300010I MANUFACTURE AND DELIVERY OF MAB ANTHRAX ANTITOXINS - MODIFICATION P0007 IS TO DEOBLIGATE THE REMAINING FUNDS AND CLOSE THE ORDER. | Department of Health and Human Services | — | Apr 7, 2026 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier ELP1DCK8L191, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.